in the ex vivo studies , platelet count , bleeding time , plasma beta-thromboglobulin , platelet aggregation induced by adp , ristocetin , and epinephrine , activated partial thromboplastin time , prothrombin time , thrombin clotting time , and serum fibrinogen degradation products were evaluated at days 0 , 3 , and 6 and at 72 h after the end of therapy .
C0032105
plasma
C0229671
serum